1. Werida, R.H., A.M. El-Okaby and N.M. El-Khodary, 2020. Evaluation of levofloxacin utilization in intensive care units of tertiary care hospital: A retrospective observational study. Drugs Ther. Perspect., 36: 33-39.
   CrossRef  |  Direct Link  |  
2. Werida, R., I. Khairat, L. Khedr and A.E.D. El-Sisi, 2019. Comparative effects of enalapril versus perindopril on serum levels of leptin and adiponectin in hypertensive patients. Acta Cardiol., 10.1080/00015385.2019.1636533.
   CrossRef  |  Direct Link  |  
3. Werida, R., L. Khedr, A. El-Din El-Sisi and M. Salama, 2018. Effect of rosuvastatin on serum levels of vaspin and visfatin in patients with CAD. Curr. Res. Cardiol., 5: 26-29.
4. El-Bahrawy, H., S. Hegazy, W. Farrag and R. Werida, 2017. Targeting inflammation using celecoxib with glimepiride in the treatment of obese type 2 diabetic Egyptian patients. Int. J. Diabet. Dev. Count., 37: 97-102.
   CrossRef  |  Direct Link  |  
5. El-Bahrawy, H., S. Hegazy, W. Farrag and R. Werida, 2014. Correlation between adipocytokines and insulin resistance in obese and non obese type 2 diabetic Egyptian patients. J. Pharm. Biol. Sci., 2: 12-18.
6. El-Bahrawy, H.A., S.K. Hegazy, W.F. Farrag and R.H. Werida, 2013. Effect of celecoxib and glimepiride on insulin resistance and adipocytokines levels in obese and non obese type 2 diabetic patients. Int. J. Med. Med. Sci., 46: 1414-1422.